10 Years of GWAS Discovery: Biology, Function, and Translation

American Journal of Human Genetics

Volumn 101, Issue 1, 2017, Pages 5-22

  Visscher, Peter M ^a   Wray, Naomi R ^a   Zhang, Qian ^a   Sklar, Pamela ^b   McCarthy, Mark I ^c,d,e   Brown, Matthew A ^f   Yang, Jian ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e CHURCHILL HOSPITAL   (United Kingdom)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

auto immune disease; genome wide association study; heritability; obesity; schizophrenia; SNP

Indexed keywords

AUTOIMMUNE DISEASE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC TRAIT; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INFORMATION RETRIEVAL; METHODOLOGY; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLEIOTROPY; PREDICTION; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE GENOME SEQUENCING; GENETIC PREDISPOSITION; GENETICS; MULTIFACTORIAL INHERITANCE; TRANSLATIONAL RESEARCH;

GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIFACTORIAL INHERITANCE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85026709756     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2017.06.005     Document Type: Review

References (145)

1. Visscher, P.M., Brown, M.A., McCarthy, M.I., Yang, J., Five years of GWAS discovery. Am. J. Hum. Genet. 90 (2012), 7–24.
2. Zhang, F., Gu, W., Hurles, M.E., Lupski, J.R., Copy number variation in human health, disease, and evolution. Annu. Rev. Genomics Hum. Genet. 10 (2009), 451–481.
3. Hudson, R.R., Properties of a neutral allele model with intragenic recombination. Theor. Popul. Biol. 23 (1983), 183–201.
4. Wray, N.R., Allele frequencies and the r2 measure of linkage disequilibrium: impact on design and interpretation of association studies. Twin Res. Hum. Genet. 8 (2005), 87–94.
5. Browning, S.R., Browning, B.L., Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 81 (2007), 1084–1097.
6. Li, Y., Willer, C.J., Ding, J., Scheet, P., Abecasis, G.R., MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34 (2010), 816–834.
7. Marchini, J., Howie, B., Myers, S., McVean, G., Donnelly, P., A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39 (2007), 906–913.
8. McCarthy, S., Das, S., Kretzschmar, W., Delaneau, O., Wood, A.R., Teumer, A., Kang, H.M., Fuchsberger, C., Danecek, P., Sharp, K., et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48 (2016), 1279–1283.
9. Yang, J., Wray, N.R., Visscher, P.M., Comparing apples and oranges: equating the power of case-control and quantitative trait association studies. Genet. Epidemiol. 34 (2010), 254–257.
10. Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., Parkinson, H., The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42 (2014), D1001–D1006.
11. Torgerson, D.G., Ampleford, E.J., Chiu, G.Y., Gauderman, W.J., Gignoux, C.R., Graves, P.E., Himes, B.E., Levin, A.M., Mathias, R.A., Hancock, D.B., et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat. Genet. 43 (2011), 887–892.
12. Marigorta, U.M., Navarro, A., High trans-ethnic replicability of GWAS results implies common causal variants. PLoS Genet., 9, 2013, e1003566.
13. Wray, N.R., Goddard, M.E., Visscher, P.M., Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 17 (2007), 1520–1528.
14. International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460 (2009), 748–752.
15. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (2014), 421–427.
16. Maher, B., Personal genomes: The case of the missing heritability. Nature 456 (2008), 18–21.
17. Manolio, T.A., Collins, F.S., Cox, N.J., Goldstein, D.B., Hindorff, L.A., Hunter, D.J., McCarthy, M.I., Ramos, E.M., Cardon, L.R., Chakravarti, A., et al. Finding the missing heritability of complex diseases. Nature 461 (2009), 747–753.
18. Wood, A.R., Esko, T., Yang, J., Vedantam, S., Pers, T.H., Gustafsson, S., Chu, A.Y., Estrada, K., Luan, J., Kutalik, Z., et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46 (2014), 1173–1186.
19. Lynch, M., Walsh, B., Genetics and analysis of quantitative traits. 1998, Sinauer Associates.
20. Bulik-Sullivan, B., Finucane, H.K., Anttila, V., Gusev, A., Day, F.R., Loh, P.R. ReproGen Consortium Psychiatric Genomics Consortium Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Duncan, L., et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47 (2015), 1236–1241.
21. Pickrell, J.K., Berisa, T., Liu, J.Z., Ségurel, L., Tung, J.Y., Hinds, D.A., Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48 (2016), 709–717.
22. Sivakumaran, S., Agakov, F., Theodoratou, E., Prendergast, J.G., Zgaga, L., Manolio, T., Rudan, I., McKeigue, P., Wilson, J.F., Campbell, H., Abundant pleiotropy in human complex diseases and traits. Am. J. Hum. Genet. 89 (2011), 607–618.
23. Parkes, M., Cortes, A., van Heel, D.A., Brown, M.A., Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14 (2013), 661–673.
24. Ellinghaus, D., Jostins, L., Spain, S.L., Cortes, A., Bethune, J., Han, B., Park, Y.R., Raychaudhuri, S., Pouget, J.G., Hübenthal, M., et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48 (2016), 510–518.
25. Li, Y.R., Zhao, S.D., Li, J., Bradfield, J.P., Mohebnasab, M., Steel, L., Kobie, J., Abrams, D.J., Mentch, F.D., Glessner, J.T., et al. Genetic sharing and heritability of paediatric age of onset autoimmune diseases. Nat. Commun., 6, 2015, 8442.
26. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45 (2013), 984–994.
27. Visscher, P.M., Yang, J., A plethora of pleiotropy across complex traits. Nat. Genet. 48 (2016), 707–708.
28. Yu, J., Pressoir, G., Briggs, W.H., Vroh Bi, I., Yamasaki, M., Doebley, J.F., McMullen, M.D., Gaut, B.S., Nielsen, D.M., Holland, J.B., et al. A unified mixed-model method for association mapping that accounts for multiple levels of relatedness. Nat. Genet. 38 (2006), 203–208.
29. Kang, H.M., Sul, J.H., Service, S.K., Zaitlen, N.A., Kong, S.Y., Freimer, N.B., Sabatti, C., Eskin, E., Variance component model to account for sample structure in genome-wide association studies. Nat. Genet. 42 (2010), 348–354.
30. Lippert, C., Listgarten, J., Liu, Y., Kadie, C.M., Davidson, R.I., Heckerman, D., FaST linear mixed models for genome-wide association studies. Nat. Methods 8 (2011), 833–835.
31. Zhou, X., Stephens, M., Genome-wide efficient mixed-model analysis for association studies. Nat. Genet. 44 (2012), 821–824.
32. Svishcheva, G.R., Axenovich, T.I., Belonogova, N.M., van Duijn, C.M., Aulchenko, Y.S., Rapid variance components-based method for whole-genome association analysis. Nat. Genet. 44 (2012), 1166–1170.
33. Yang, J., Zaitlen, N.A., Goddard, M.E., Visscher, P.M., Price, A.L., Advantages and pitfalls in the application of mixed-model association methods. Nat. Genet. 46 (2014), 100–106.
34. Loh, P.R., Tucker, G., Bulik-Sullivan, B.K., Vilhjálmsson, B.J., Finucane, H.K., Salem, R.M., Chasman, D.I., Ridker, P.M., Neale, B.M., Berger, B., et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat. Genet. 47 (2015), 284–290.
35. Liu, J.Z., McRae, A.F., Nyholt, D.R., Medland, S.E., Wray, N.R., Brown, K.M., Hayward, N.K., Montgomery, G.W., Visscher, P.M., Martin, N.G., Macgregor, S., AMFS Investigators. A versatile gene-based test for genome-wide association studies. Am. J. Hum. Genet. 87 (2010), 139–145.
36. Li, M.X., Gui, H.S., Kwan, J.S., Sham, P.C., GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am. J. Hum. Genet. 88 (2011), 283–293.
37. Yang, J., Ferreira, T., Morris, A.P., Medland, S.E. Genetic Investigation of ANthropometric Traits (GIANT) Consortium DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Madden, P.A., Heath, A.C., Martin, N.G., Montgomery, G.W., et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44 (2012), 369–375 S1–S3.
38. Finucane, H.K., Bulik-Sullivan, B., Gusev, A., Trynka, G., Reshef, Y., Loh, P.R., Anttila, V., Xu, H., Zang, C., Farh, K., et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47 (2015), 1228–1235.
39. Yang, J., Benyamin, B., McEvoy, B.P., Gordon, S., Henders, A.K., Nyholt, D.R., Madden, P.A., Heath, A.C., Martin, N.G., Montgomery, G.W., et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42 (2010), 565–569.
40. Bowden, J., Davey Smith, G., Burgess, S., Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44 (2015), 512–525.
41. Burgess, S., Butterworth, A., Thompson, S.G., Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37 (2013), 658–665.
42. Smith, G.D., Ebrahim, S., ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?. Int. J. Epidemiol. 32 (2003), 1–22.
43. Jia, X., Han, B., Onengut-Gumuscu, S., Chen, W.M., Concannon, P.J., Rich, S.S., Raychaudhuri, S., de Bakker, P.I., Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE, 8, 2013, e64683.
44. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., Abecasis, G.R., Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44 (2012), 955–959.
45. Huang, J., Howie, B., McCarthy, S., Memari, Y., Walter, K., Min, J.L., Danecek, P., Malerba, G., Trabetti, E., Zheng, H.F., et al. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nat. Commun., 6, 2015, 8111.
46. Browning, B.L., Browning, S.R., Genotype Imputation with Millions of Reference Samples. Am. J. Hum. Genet. 98 (2016), 116–126.
47. Visscher, P.M., Hill, W.G., Wray, N.R., Heritability in the genomics era–concepts and misconceptions. Nat. Rev. Genet. 9 (2008), 255–266.
48. Yang, J., Lee, T., Kim, J., Cho, M.C., Han, B.G., Lee, J.Y., Lee, H.J., Cho, S., Kim, H., Ubiquitous polygenicity of human complex traits: genome-wide analysis of 49 traits in Koreans. PLoS Genet., 9, 2013, e1003355.
49. Yang, J., Bakshi, A., Zhu, Z., Hemani, G., Vinkhuyzen, A.A., Lee, S.H., Robinson, M.R., Perry, J.R., Nolte, I.M., van Vliet-Ostaptchouk, J.V., et al. Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nat. Genet. 47 (2015), 1114–1120.
50. Moser, G., Lee, S.H., Hayes, B.J., Goddard, M.E., Wray, N.R., Visscher, P.M., Simultaneous discovery, estimation and prediction analysis of complex traits using a bayesian mixture model. PLoS Genet., 11, 2015, e1004969.
51. van Rheenen, W., Shatunov, A., Dekker, A.M., McLaughlin, R.L., Diekstra, F.P., Pulit, S.L., van der Spek, R.A., Võsa, U., de Jong, S., Robinson, M.R., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 48 (2016), 1043–1048.
52. Ripke, S., O'Dushlaine, C., Chambert, K., Moran, J.L., Kähler, A.K., Akterin, S., Bergen, S.E., Collins, A.L., Crowley, J.J., Fromer, M., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45 (2013), 1150–1159.
53. Loh, P.R., Bhatia, G., Gusev, A., Finucane, H.K., Bulik-Sullivan, B.K., Pollack, S.J. Schizophrenia Working Group of Psychiatric Genomics Consortium, de Candia, T.R., Lee, S.H., Wray, N.R., et al. Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis. Nat. Genet. 47 (2015), 1385–1392.
54. Cortes, A., Pulit, S.L., Leo, P.J., Pointon, J.J., Robinson, P.C., Weisman, M.H., Ward, M., Gensler, L.S., Zhou, X., Garchon, H.J., et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat. Commun., 6, 2015, 7146.
55. Evans, D.M., Visscher, P.M., Wray, N.R., Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk. Hum. Mol. Genet. 18 (2009), 3525–3531.
56. Gamazon, E.R., Wheeler, H.E., Shah, K.P., Mozaffari, S.V., Aquino-Michaels, K., Carroll, R.J., Eyler, A.E., Denny, J.C. GTEx Consortium, Nicolae, D.L., et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47 (2015), 1091–1098.
57. Evans, D.M., Brion, M.J., Paternoster, L., Kemp, J.P., McMahon, G., Munafò, M., Whitfield, J.B., Medland, S.E., Montgomery, G.W., GIANT Consortium, et al. Mining the human phenome using allelic scores that index biological intermediates. PLoS Genet., 9, 2013, e1003919.
58. Tyrrell, J., Wood, A.R., Ames, R.M., Yaghootkar, H., Beaumont, R.N., Jones, S.E., Tuke, M.A., Ruth, K.S., Freathy, R.M., Davey Smith, G., et al. Gene-obesogenic environment interactions in the UK Biobank study. Int. J. Epidemiol. 46 (2017), 559–575.
59. Zheng, J., Erzurumluoglu, A.M., Elsworth, B.L., Kemp, J.P., Howe, L., Haycock, P.C., Hemani, G., Tansey, K., Laurin, C., Early Genetics and Lifecourse Epidemiology (EAGLE) Eczema Consortium, et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33 (2017), 272–279.
60. Hoffmann, T.J., Ehret, G.B., Nandakumar, P., Ranatunga, D., Schaefer, C., Kwok, P.Y., Iribarren, C., Chakravarti, A., Risch, N., Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nat. Genet. 49 (2017), 54–64.
61. Gusev, A., Ko, A., Shi, H., Bhatia, G., Chung, W., Penninx, B.W., Jansen, R., de Geus, E.J., Boomsma, D.I., Wright, F.A., et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48 (2016), 245–252.
62. Zhu, Z., Zhang, F., Hu, H., Bakshi, A., Robinson, M.R., Powell, J.E., Montgomery, G.W., Goddard, M.E., Wray, N.R., Visscher, P.M., Yang, J., Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48 (2016), 481–487.
63. Bulik-Sullivan, B.K., Loh, P.R., Finucane, H.K., Ripke, S., Yang, J. Schizophrenia Working Group of the Psychiatric Genomics Consortium, Patterson, N., Daly, M.J., Price, A.L., Neale, B.M., LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47 (2015), 291–295.
64. Claussnitzer, M., Dankel, S.N., Kim, K.H., Quon, G., Meuleman, W., Haugen, C., Glunk, V., Sousa, I.S., Beaudry, J.L., Puviindran, V., et al. FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N. Engl. J. Med. 373 (2015), 895–907.
65. Sekar, A., Bialas, A.R., de Rivera, H., Davis, A., Hammond, T.R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. Schizophrenia risk from complex variation of complement component 4. Nature 530 (2016), 177–183.
66. Albert, F.W., Kruglyak, L., The role of regulatory variation in complex traits and disease. Nat. Rev. Genet. 16 (2015), 197–212.
67. Pasquali, L., Gaulton, K.J., Rodríguez-Seguí, S.A., Mularoni, L., Miguel-Escalada, I., Akerman, I., Tena, J.J., Morán, I., Gómez-Marín, C., van de Bunt, M., et al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat. Genet. 46 (2014), 136–143.
68. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489 (2012), 57–74.
69. Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. Integrative analysis of 111 reference human epigenomes. Nature 518 (2015), 317–330.
70. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45 (2013), 580–585.
71. Won, H., de la Torre-Ubieta, L., Stein, J.L., Parikshak, N.N., Huang, J., Opland, C.K., Gandal, M.J., Sutton, G.J., Hormozdiari, F., Lu, D., et al. Chromosome conformation elucidates regulatory relationships in developing human brain. Nature 538 (2016), 523–527.
72. Nelson, M.R., Tipney, H., Painter, J.L., Shen, J., Nicoletti, P., Shen, Y., Floratos, A., Sham, P.C., Li, M.J., Wang, J., et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47 (2015), 856–860.
73. McDonald, T.J., Ellard, S., Maturity onset diabetes of the young: identification and diagnosis. Ann. Clin. Biochem. 50 (2013), 403–415.
74. Fuchsberger, C., Flannick, J., Teslovich, T.M., Mahajan, A., Agarwala, V., Gaulton, K.J., Ma, C., Fontanillas, P., Moutsianas, L., McCarthy, D.J., et al. The genetic architecture of type 2 diabetes. Nature 536 (2016), 41–47.
75. DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium South Asian Type 2 Diabetes (SAT2D) Consortium Mexican American Type 2 Diabetes (MAT2D) Consortium Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples (T2D-GENES) Consortium, Mahajan, A., Go, M.J., Zhang, W., Below, J.E., Gaulton, K.J., et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46 (2014), 234–244.
76. Morris, A.P., Voight, B.F., Teslovich, T.M., Ferreira, T., Segrè, A.V., Steinthorsdottir, V., Strawbridge, R.J., Khan, H., Grallert, H., Mahajan, A., et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44 (2012), 981–990.
77. Steinthorsdottir, V., Thorleifsson, G., Sulem, P., Helgason, H., Grarup, N., Sigurdsson, A., Helgadottir, H.T., Johannsdottir, H., Magnusson, O.T., Gudjonsson, S.A., et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat. Genet. 46 (2014), 294–298.
78. Ayub, Q., Moutsianas, L., Chen, Y., Panoutsopoulou, K., Colonna, V., Pagani, L., Prokopenko, I., Ritchie, G.R., Tyler-Smith, C., McCarthy, M.I., et al. Revisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetes. Am. J. Hum. Genet. 94 (2014), 176–185.
79. Field, Y., Boyle, E.A., Telis, N., Gao, Z., Gaulton, K.J., Golan, D., Yengo, L., Rocheleau, G., Froguel, P., McCarthy, M.I., Pritchard, J.K., Detection of human adaptation during the past 2000 years. Science 354 (2016), 760–764.
80. Waters, K.M., Stram, D.O., Hassanein, M.T., Le Marchand, L., Wilkens, L.R., Maskarinec, G., Monroe, K.R., Kolonel, L.N., Altshuler, D., Henderson, B.E., Haiman, C.A., Consistent association of type 2 diabetes risk variants found in europeans in diverse racial and ethnic groups. PLoS Genet., 6, 2010, e1001078.
81. Moltke, I., Grarup, N., Jørgensen, M.E., Bjerregaard, P., Treebak, J.T., Fumagalli, M., Korneliussen, T.S., Andersen, M.A., Nielsen, T.S., Krarup, N.T., et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 512 (2014), 190–193.
82. Claussnitzer, M., Dankel, S.N., Klocke, B., Grallert, H., Glunk, V., Berulava, T., Lee, H., Oskolkov, N., Fadista, J., Ehlers, K., et al. Leveraging cross-species transcription factor binding site patterns: from diabetes risk loci to disease mechanisms. Cell 156 (2014), 343–358.
83. Scott, L.J., Erdos, M.R., Huyghe, J.R., Welch, R.P., Beck, A.T., Wolford, B.N., Chines, P.S., Didion, J.P., Narisu, N., Stringham, H.M., et al. The genetic regulatory signature of type 2 diabetes in human skeletal muscle. Nat. Commun., 7, 2016, 11764.
84. Parker, S.C., Stitzel, M.L., Taylor, D.L., Orozco, J.M., Erdos, M.R., Akiyama, J.A., van Bueren, K.L., Chines, P.S., Narisu, N., NISC Comparative Sequencing Program, et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. USA 110 (2013), 17921–17926.
85. Small, K.S., Hedman, A.K., Grundberg, E., Nica, A.C., Thorleifsson, G., Kong, A., Thorsteindottir, U., Shin, S.Y., Richards, H.B., GIANT Consortium, et al. Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat. Genet. 43 (2011), 561–564.
86. Gaulton, K.J., Ferreira, T., Lee, Y., Raimondo, A., Mägi, R., Reschen, M.E., Mahajan, A., Locke, A., Rayner, N.W., Robertson, N., et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47 (2015), 1415–1425.
87. Dimas, A.S., Lagou, V., Barker, A., Knowles, J.W., Mägi, R., Hivert, M.F., Benazzo, A., Rybin, D., Jackson, A.U., Stringham, H.M., et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63 (2014), 2158–2171.
88. van de Bunt, M., Manning Fox, J.E., Dai, X., Barrett, A., Grey, C., Li, L., Bennett, A.J., Johnson, P.R., Rajotte, R.V., Gaulton, K.J., et al. Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors. PLoS Genet., 11, 2015, e1005694.
89. Saxena, R., Hivert, M.F., Langenberg, C., Tanaka, T., Pankow, J.S., Vollenweider, P., Lyssenko, V., Bouatia-Naji, N., Dupuis, J., Jackson, A.U., et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat. Genet. 42 (2010), 142–148.
90. Kooner, J.S., Saleheen, D., Sim, X., Sehmi, J., Zhang, W., Frossard, P., Been, L.F., Chia, K.S., Dimas, A.S., Hassanali, N., et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat. Genet. 43 (2011), 984–989.
91. Sandhu, M.S., Weedon, M.N., Fawcett, K.A., Wasson, J., Debenham, S.L., Daly, A., Lango, H., Frayling, T.M., Neumann, R.J., Sherva, R., et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat. Genet. 39 (2007), 951–953.
92. Wei, F.Y., Tomizawa, K., Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes. Endocr. J. 58 (2011), 819–825.
93. Flannick, J., Thorleifsson, G., Beer, N.L., Jacobs, S.B., Grarup, N., Burtt, N.P., Mahajan, A., Fuchsberger, C., Atzmon, G., Benediktsson, R., et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat. Genet. 46 (2014), 357–363.
94. Fall, T., Xie, W., Poon, W., Yaghootkar, H., Mägi, R. GENESIS Consortium, Knowles, J.W., Lyssenko, V., Weedon, M., Frayling, T.M., Ingelsson, E., Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes. Diabetes 64 (2015), 2676–2684.
95. Horikoshi, M., Beaumont, R.N., Day, F.R., Warrington, N.M., Kooijman, M.N., Fernandez-Tajes, J., Feenstra, B., van Zuydam, N.R., Gaulton, K.J., Grarup, N., et al. Genome-wide associations for birth weight and correlations with adult disease. Nature 538 (2016), 248–252.
96. Lotta, L.A., Sharp, S.J., Burgess, S., Perry, J.R., Stewart, I.D., Willems, S.M., Luan, J., Ardanaz, E., Arriola, L., Balkau, B., et al. Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. JAMA 316 (2016), 1383–1391.
97. Rafiq, S., Melzer, D., Weedon, M.N., Lango, H., Saxena, R., Scott, L.J. DIAGRAM Consortium, Palmer, C.N., Morris, A.D., McCarthy, et al. Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Diabetologia 51 (2008), 2205–2213.
98. Ye, Z., Sharp, S.J., Burgess, S., Scott, R.A., Imamura, F. InterAct Consortium, Langenberg, C., Wareham, N.J., Forouhi, N.G., Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 3 (2015), 35–42.
99. Lotta, L.A., Gulati, P., Day, F.R., Payne, F., Ongen, H., van de Bunt, M., Gaulton, K.J., Eicher, J.D., Sharp, S.J., Luan, J., et al. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat. Genet. 49 (2017), 17–26.
100. GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group Wellcome Trust Case Control Consortium 2, Zhou, K., Bellenguez, C., Spencer, C.C., Bennett, A.J., Coleman, R.L., Tavendale, R., Hawley, S.A., Donnelly, L.A., et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat. Genet. 43 (2011), 117–120.
101. Zhou, K., Yee, S.W., Seiser, E.L., van Leeuwen, N., Tavendale, R., Bennett, A.J., Groves, C.J., Coleman, R.L., van der Heijden, A.A., Beulens, J.W., et al. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nat. Genet. 48 (2016), 1055–1059.
102. Gloyn, A.L., Pearson, E.R., Antcliff, J.F., Proks, P., Bruining, G.J., Slingerland, A.S., Howard, N., Srinivasan, S., Silva, J.M., Molnes, J., et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 350 (2004), 1838–1849.
103. Lynch, C.J., Adams, S.H., Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 10 (2014), 723–736.
104. Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Nielsen, T., Jensen, B.A., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 (2016), 376–381.
105. Cortes, A., Brown, M.A., Promise and pitfalls of the Immunochip. Arthritis Res. Ther., 13, 2011, 101.
106. Liu, J.Z., van Sommeren, S., Huang, H., Ng, S.C., Alberts, R., Takahashi, A., Ripke, S., Lee, J.C., Jostins, L., Shah, T., et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47 (2015), 979–986.
107. Jiang, L., Yin, J., Ye, L., Yang, J., Hemani, G., Liu, A.J., Zou, H., He, D., Sun, L., Zeng, X., et al. Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans. Arthritis Rheumatol. 66 (2014), 1121–1132.
108. Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., Suzuki, A., Yoshida, S., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506 (2014), 376–381.
109. International Genetics of Ankylosing Spondylitis Consortium (IGAS), Cortes, A., Hadler, J., Pointon, J.P., Robinson, P.C., Karaderi, T., Leo, P., Cremin, K., Pryce, K., Harris, J., et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45 (2013), 730–738.
110. Gregory, A.P., Dendrou, C.A., Attfield, K.E., Haghikia, A., Xifara, D.K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O.A., et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488 (2012), 508–511.
111. Gregersen, P.K., Silver, J., Winchester, R.J., The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30 (1987), 1205–1213.
112. Raychaudhuri, S., Sandor, C., Stahl, E.A., Freudenberg, J., Lee, H.S., Jia, X., Alfredsson, L., Padyukov, L., Klareskog, L., Worthington, J., et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44 (2012), 291–296.
113. Scally, S.W., Petersen, J., Law, S.C., Dudek, N.L., Nel, H.J., Loh, K.L., Wijeyewickrema, L.C., Eckle, S.B., van Heemst, J., Pike, R.N., et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 210 (2013), 2569–2582.
114. Heap, G.A., Weedon, M.N., Bewshea, C.M., Singh, A., Chen, M., Satchwell, J.B., Vivian, J.P., So, K., Dubois, P.C., Andrews, J.M., et al. HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nat. Genet. 46 (2014), 1131–1134.
115. Hueber, W., Patel, D.D., Dryja, T., Wright, A.M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M.H., Psoriasis Study Group, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med., 2, 2010, 52ra72.
116. McInnes, I.B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J.D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial. Ann. Rheum. Dis. 73 (2014), 349–356.
117. Sieper, J., Deodhar, A., Marzo-Ortega, H., Aelion, J.A., Blanco, R., Jui-Cheng, T., Andersson, M., Porter, B., Richards, H.B., MEASURE 2 Study Group. Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study. Ann. Rheum. Dis. 76 (2017), 571–592.
118. Subramanian, V., Knight, J.S., Parelkar, S., Anguish, L., Coonrod, S.A., Kaplan, M.J., Thompson, P.R., Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors. J. Med. Chem. 58 (2015), 1337–1344.
119. Kawalkowska, J., Quirke, A.M., Ghari, F., Davis, S., Subramanian, V., Thompson, P.R., Williams, R.O., Fischer, R., La Thangue, N.B., Venables, P.J., Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses. Sci. Rep., 6, 2016, 26430.
120. Agrawal, N., Brown, M.A., Genetic associations and functional characterization of M1 aminopeptidases and immune-mediated diseases. Genes Immun. 15 (2014), 521–527.
121. CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium, Psychosis Endophenotypes International Consortium. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 49 (2017), 27–35.
122. Girard, S.L., Gauthier, J., Noreau, A., Xiong, L., Zhou, S., Jouan, L., Dionne-Laporte, A., Spiegelman, D., Henrion, E., Diallo, O., et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat. Genet. 43 (2011), 860–863.
123. Xu, B., Roos, J.L., Dexheimer, P., Boone, B., Plummer, B., Levy, S., Gogos, J.A., Karayiorgou, M., Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat. Genet. 43 (2011), 864–868.
124. Fromer, M., Pocklington, A.J., Kavanagh, D.H., Williams, H.J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D.M., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506 (2014), 179–184.
125. De Rubeis, S., He, X., Goldberg, A.P., Poultney, C.S., Samocha, K., Cicek, A.E., Kou, Y., Liu, L., Fromer, M., Walker, S., et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515 (2014), 209–215.
126. McCarthy, S.E., Gillis, J., Kramer, M., Lihm, J., Yoon, S., Berstein, Y., Mistry, M., Pavlidis, P., Solomon, R., Ghiban, E., et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol. Psychiatry 19 (2014), 652–658.
127. Jiang, Y.H., Yuen, R.K., Jin, X., Wang, M., Chen, N., Wu, X., Ju, J., Mei, J., Shi, Y., He, M., et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am. J. Hum. Genet. 93 (2013), 249–263.
128. Iossifov, I., O'Roak, B.J., Sanders, S.J., Ronemus, M., Krumm, N., Levy, D., Stessman, H.A., Witherspoon, K.T., Vives, L., Patterson, K.E., et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515 (2014), 216–221.
129. Georgieva, L., Rees, E., Moran, J.L., Chambert, K.D., Milanova, V., Craddock, N., Purcell, S., Sklar, P., McCarroll, S., Holmans, P., et al. De novo CNVs in bipolar affective disorder and schizophrenia. Hum. Mol. Genet. 23 (2014), 6677–6683.
130. Roussos, P., Mitchell, A.C., Voloudakis, G., Fullard, J.F., Pothula, V.M., Tsang, J., Stahl, E.A., Georgakopoulos, A., Ruderfer, D.M., Charney, A., et al. A role for noncoding variation in schizophrenia. Cell Rep. 9 (2014), 1417–1429.
131. Gusev, A., Lee, S.H., Trynka, G., Finucane, H., Vilhjálmsson, B.J., Xu, H., Zang, C., Ripke, S., Bulik-Sullivan, B., Stahl, E., et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am. J. Hum. Genet. 95 (2014), 535–552.
132. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18 (2015), 199–209.
133. de Jong, S., Vidler, L.R., Mokrab, Y., Collier, D.A., Breen, G., Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia. J. Psychopharmacol. (Oxford) 30 (2016), 826–830.
134. Bell, J.T., Pai, A.A., Pickrell, J.K., Gaffney, D.J., Pique-Regi, R., Degner, J.F., Gilad, Y., Pritchard, J.K., DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol., 12, 2011, R10.
135. Kettunen, J., Tukiainen, T., Sarin, A.P., Ortega-Alonso, A., Tikkanen, E., Lyytikäinen, L.P., Kangas, A.J., Soininen, P., Würtz, P., Silander, K., et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat. Genet. 44 (2012), 269–276.
136. Shah, S., McRae, A.F., Marioni, R.E., Harris, S.E., Gibson, J., Henders, A.K., Redmond, P., Cox, S.R., Pattie, A., Corley, J., et al. Genetic and environmental exposures constrain epigenetic drift over the human life course. Genome Res. 24 (2014), 1725–1733.
137. Shah, S., Bonder, M.J., Marioni, R.E., Zhu, Z., McRae, A.F., Zhernakova, A., Harris, S.E., Liewald, D., Henders, A.K., Mendelson, M.M., et al. Improving Phenotypic Prediction by Combining Genetic and Epigenetic Associations. Am. J. Hum. Genet. 97 (2015), 75–85.
138. Marouli, E., Graff, M., Medina-Gomez, C., Lo, K.S., Wood, A.R., Kjaer, T.R., Fine, R.S., Lu, Y., Schurmann, C., Highland, H.M., et al. Rare and low-frequency coding variants alter human adult height. Nature 542 (2017), 186–190.
139. Farh, K.K., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W.J., Beik, S., Shoresh, N., Whitton, H., Ryan, R.J., Shishkin, A.A., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518 (2015), 337–343.
140. Spain, S.L., Barrett, J.C., Strategies for fine-mapping complex traits. Hum. Mol. Genet. 24:R1 (2015), R111–R119.
141. He, X., Fuller, C.K., Song, Y., Meng, Q., Zhang, B., Yang, X., Li, H., Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. Am. J. Hum. Genet. 92 (2013), 667–680.
142. Hormozdiari, F., Kostem, E., Kang, E.Y., Pasaniuc, B., Eskin, E., Identifying causal variants at loci with multiple signals of association. Genetics 198 (2014), 497–508.
143. Morris, A.P., Transethnic meta-analysis of genomewide association studies. Genet. Epidemiol. 35 (2011), 809–822.
144. Hunter, D.J., Kraft, P., Drinking from the fire hose–statistical issues in genomewide association studies. N. Engl. J. Med. 357 (2007), 436–439.
145. Risch, N., Merikangas, K., The future of genetic studies of complex human diseases. Science 273 (1996), 1516–1517.